Literature DB >> 2000399

Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse C3H/10T1/2 cells treated with radiation and phorbol 12-myristate 13-acetate.

C Borek1, A Ong, V L Stevens, E Wang, A H Merrill.   

Abstract

Sphingosine and other long-chain (sphingoid) bases inhibit protein kinase C, the putative cellular receptor for the tumor promoter phorbol 12-myristate 13-acetate (PMA), and exert potent effects on diverse cell functions. We tested the ability of long-chain bases to modulate multistage carcinogenesis in mouse C3H/10T1/2 cells exposed to gamma-rays and PMA. Sphingosine and sphinganine completely blocked the enhancement of radiation-induced transformation by PMA (promotion) and partially suppressed transformation by radiation alone. N-Acetylsphingosine, a ceramide analog, did not inhibit transformation. Sphingosine was rapidly taken up by the cells and metabolized; hence, the long-chain bases were added daily to achieve prolonged inhibition. Long-chain bases inhibited protein kinase C activity in C3H/10T1/2 cells and suppressed the down-regulation of this enzyme by PMA. Our results establish that long-chain bases are highly effective inhibitors of carcinogenesis in this model. Our results also indicate that the suppressive effects may be mediated, in part, by inhibition of protein kinase C. The data suggest that sphingosine and other long-chain bases derived from complex sphingolipids may act as cancer-preventative agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000399      PMCID: PMC51144          DOI: 10.1073/pnas.88.5.1953

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Characteristics of the growth inhibition and cytotoxicity of long-chain (sphingoid) bases for Chinese hamster ovary cells: evidence for an involvement of protein kinase C.

Authors:  V L Stevens; S Nimkar; W C Jamison; D C Liotta; A H Merrill
Journal:  Biochim Biophys Acta       Date:  1990-01-23

2.  Neoplastic transformation of hamster embryo cells irradiated in utero and assayed in vitro.

Authors:  C Borek; C Pain; H Mason
Journal:  Nature       Date:  1977-03-31       Impact factor: 49.962

3.  Metabolism of cerebroside in the intestinal tract of the rat.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-07-29

4.  Distinctive transforming genes in x-ray-transformed mammalian cells.

Authors:  C Borek; A Ong; H Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.

Authors:  C M Weyman; E J Taparowsky; M Wolfson; C L Ashendel
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

6.  Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst.

Authors:  E Wilson; M C Olcott; R M Bell; A H Merrill; J D Lambeth
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

7.  Modulation of the free sphingosine levels in human neutrophils by phorbol esters and other factors.

Authors:  E Wilson; E Wang; R E Mullins; D J Uhlinger; D C Liotta; J D Lambeth; A H Merrill
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

8.  Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases.

Authors:  A H Merrill; A M Sereni; V L Stevens; Y A Hannun; R M Bell; J M Kinkade
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

Review 9.  The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

Authors:  I B Weinstein
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

10.  Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds.

Authors:  A H Merrill; S Nimkar; D Menaldino; Y A Hannun; C Loomis; R M Bell; S R Tyagi; J D Lambeth; V L Stevens; R Hunter
Journal:  Biochemistry       Date:  1989-04-18       Impact factor: 3.162

View more
  5 in total

1.  Structure of Sphingolipids From Sea Cucumber Cucumaria frondosa and Structure-Specific Cytotoxicity Against Human HepG2 Cells.

Authors:  Zicai Jia; Yu Song; Suyuan Tao; Peixu Cong; Xiaoxu Wang; Changhu Xue; Jie Xu
Journal:  Lipids       Date:  2016-02-10       Impact factor: 1.880

Review 2.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

3.  Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer.

Authors:  Holly Symolon; Anatoliy Bushnev; Qiong Peng; Harsha Ramaraju; Suzanne G Mays; Jeremy C Allegood; Sarah T Pruett; M Cameron Sullards; Dirck L Dillehay; Dennis C Liotta; Alfred H Merrill
Journal:  Mol Cancer Ther       Date:  2011-03-11       Impact factor: 6.261

4.  Sphinganine is associated with 24-h MAP in the non-sleepy with OSA.

Authors:  Victoria M Pak; Katherine Russell; Zhenzhen Shi; Qiang Zhang; John Cox; Karan Uppal; Tianwei Yu; Vicki Hertzberg; Ken Liu; Octavian C Ioachimescu; Nancy Collop; Donald L Bliwise; Nancy G Kutner; Ann Rogers; Sandra B Dunbar
Journal:  Metabolomics       Date:  2022-04-07       Impact factor: 4.290

Review 5.  Molecular mechanisms in cancer induction and prevention.

Authors:  C Borek
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.